UK-Switzerland Enhanced Free Trade Agreement
I congratulate the Minister on deal No. 6. A very warm thanks, on behalf of the Committee, to the hard-working officials in the Department for Business and Trade and to James Squire and the Foreign, Commonwealth and Development Office team on the ground in Berne. We very much look forward to scrutinising the deal on behalf of Parliament, with a debate that will no doubt be triggered in the Constitutional Reform and Governance Act period. The Minister will know, though, that there has already been some controversy this morning, about which he could perhaps inform the House. This is, I think, the first free trade agreement to lock in exclusivity arrangements around intellectual property for pharmaceuticals. That is a precedent that the House should debate. Will he take this opportunity to put our minds at rest that the deal that he is commending to us today will not lead to higher NHS prices in future, and will not impair access to generic medicines?